2026. Upfront Therapy for Non‑transplantable Multiple Myeloma in 2026: Decision‑making in an Increasingly Complex Therapeutic Landscape. Actualité hématologique au Canada. 5, 1 (juin 2026), 24–35. DOI:https://doi.org/10.58931/cht.2026.5185.